Literature DB >> 16333107

Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains.

Jannick Verbeeck1, Piet Maes, Elke Wollants, Schalk Van der Merwe, Ernie Song, Frederik Nevens, Marc Van Ranst.   

Abstract

To validate a commercially available line probe assay for samples containing the infrequently found hepatitis C virus (HCV) genotype 5a, we sequenced a 511-nucleotide fragment of the NS4b region of Belgian and South African HCV genotype 5a samples. Phylogenetic analysis of the sequence data was performed. For the 77 HCV genotype 5a samples collected, there was 100% concordance between the genotype assignment by the line probe assay and the genotyping based on nucleotide sequencing, despite sequence heterogeneity in the probe binding sites of some samples.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333107      PMCID: PMC1317178          DOI: 10.1128/JCM.43.12.6117-6119.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  Infection by genotype 5a of HCV in a district of southeast Spain.

Authors:  R Jover; J Pérez-Serra; F de Vera; J M Alamo; C Muñoz; C Yago; R Martínez-Ramírez; J V Vidal
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

3.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 4.  Hepatitis C advances in antiviral therapy: what is accepted treatment now?

Authors:  John G McHutchison
Journal:  J Gastroenterol Hepatol       Date:  2002-04       Impact factor: 4.029

5.  Biological and clinicopathological features associated with hepatitis C virus type 5 infections.

Authors:  D G Murphy; B Willems; J Vincelette; L Bernier; J Côté; G Delage
Journal:  J Hepatol       Date:  1996-01       Impact factor: 25.083

6.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.

Authors:  F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

7.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

8.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

9.  Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.

Authors:  Frederick S Nolte; Alicia M Green; Kristin R Fiebelkorn; Angela M Caliendo; Cynthia Sturchio; Aileen Grunwald; Mimi Healy
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002.

Authors:  Cécile Henquell; Carole Cartau; Armand Abergel; Henri Laurichesse; Christel Regagnon; Christophe De Champs; Jean-Luc Bailly; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more
  2 in total

1.  Investigating the origin and spread of hepatitis C virus genotype 5a.

Authors:  Jannick Verbeeck; Piet Maes; Philippe Lemey; Oliver G Pybus; Elke Wollants; Ernie Song; Frederik Nevens; Johan Fevery; Wayne Delport; Schalk Van der Merwe; Marc Van Ranst
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  HCV genotypes distribution pattern in India.

Authors:  Farah Bokharaei-Salim; Seyed Moayed Alavian
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.